WHO Prequalifies Celltrion’s Rituximab
Truxima Becomes Second Biosimilar To Be Prequalified By Organization
Executive Summary
Celltrion's Truxima has become the first rituximab biosimilar, and just the second biosimilar overall, to be prequalified by the World Health Organization.